Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

Ask Our Experts

Get answers to your specific medical questions from UM Medical Center experts.

Note: This is for informational purposes only. Doctors cannot provide a diagnosis via e-mail.

 

Related Content

Hospital for Children

Divisions/Specialties

Patient Success Stories

Our Doctors

Respiratory syncytial virus (RSV)

Alternative Names:

RSV

Treatment:

Antibiotics do not help in the treatment of RSV. Mild infections resolve without treatment. A severe infection in infants and children may require hospitalization to provide supplemental oxygen, humidified air, and hydration by intravenous fluids. Respiratory support may be needed, using a breathing machine (ventilator).

Your doctor will be the best judge as to what treatment to use. A medication to open the airways of the lungs (bronchodilator) is sometimes used. In very serious cases, antiviral drugs such as Ribavirin may be tried.

Expectations (prognosis):

RSV infection may rarely cause death in infants, but this is unlikely if the child is seen early in the course of the illness. In older children and adults, the disease will usually be quite mild. There is evidence suggesting an increased incidence of asthma in children who have developed RSV bronchiolitis. It is unknown whether the factors that predispose the child to asthma also predisposed him to developing bronchiolitis as an infant, or if the RSV bronchiolitis itself predisposes the child to develop asthma later.

Complications:

Calling your health care provider:

Call your health care provider if breathing difficulties or other symptoms of this disorder appear. Any breathing difficulties in an infant should be regarded as an emergency and the appropriate help sought.

References:

Meissner HC, Long SS; American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003 Dec;112(6 Pt 1):1447-52.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

adam.com